Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4583840
Max Phase: Preclinical
Molecular Formula: C9H5Cl2NS
Molecular Weight: 230.12
Molecule Type: Unknown
Associated Items:
ID: ALA4583840
Max Phase: Preclinical
Molecular Formula: C9H5Cl2NS
Molecular Weight: 230.12
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Clc1cc(-c2cccnc2)c(Cl)s1
Standard InChI: InChI=1S/C9H5Cl2NS/c10-8-4-7(9(11)13-8)6-2-1-3-12-5-6/h1-5H
Standard InChI Key: IREJLCMOXVWXKN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 230.12 | Molecular Weight (Monoisotopic): 228.9520 | AlogP: 4.12 | #Rotatable Bonds: 1 |
Polar Surface Area: 12.89 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 4.55 | CX LogP: 3.72 | CX LogD: 3.72 |
Aromatic Rings: 2 | Heavy Atoms: 13 | QED Weighted: 0.72 | Np Likeness Score: -1.75 |
1. (2013) Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer, |
Source(1):